BRIEF published on 06/21/2024 at 11:21, 2 years ago Heidelberg Pharma Reports on the Results of the Annual General Meeting 2024 Shareholders Financial News Resolutions Heidelberg Pharma AGM 2024
BRIEF published on 06/21/2024 at 11:21, 2 years ago Heidelberg Pharma rend compte des résultats de l'Assemblée générale annuelle 2024 Actionnaires Resolutions Heidelberg Pharma Actualités Financières AGA 2024
PRESS RELEASE published on 06/21/2024 at 11:16, 2 years ago Heidelberg Pharma reports on the results of the Annual General Meeting 2024 Heidelberg Pharma AG reports on the results of the Annual General Meeting 2024, including approval of resolutions and shareholder attendance Shareholders Voting Results Annual General Meeting 2024 Cancer Therapy Heidelberg Pharma AG
BRIEF published on 06/18/2024 at 13:52, 2 years ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
BRIEF published on 06/18/2024 at 13:52, 2 years ago Heidelberg Pharma AG annonce des prévisions mises à jour pour 2024 Conseils Financiers Prévisions De Revenus Heidelberg Pharma SA Biotechnologies Dépenses De Fonctionnement
PRESS RELEASE published on 06/18/2024 at 13:47, 2 years ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 2 years 1 month ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
BRIEF published on 05/23/2024 at 09:17, 2 years 1 month ago Heidelberg Pharma participera et présentera des conférences scientifiques de premier plan à venir en mai et juin 2024 Conférences Traitement Du Cancer Heidelberg Pharma HDP-101 ADC
PRESS RELEASE published on 05/23/2024 at 09:12, 2 years 1 month ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 2 years 2 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
Published on 07/14/2026 at 01:45, 9 hours 33 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 11 hours 17 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 12 hours 8 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 13 hours 43 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 15 hours 18 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 11:05, 13 minutes ago Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care
Published on 07/14/2026 at 11:05, 13 minutes ago Yilu Liu, Yushan Yan, Johann W. Kolar have been chosen as laureates of Global Energy Prize 2026
Published on 07/14/2026 at 11:00, 18 minutes ago Growth financing: SIXT places EUR 500 million bond – order book more than three times oversubscribed
Published on 07/14/2026 at 10:58, 20 minutes ago EQS-Adhoc: Semperit AG Holding: Operating earnings in Q2 2026 significantly above the prior-year figure; full-year earnings forecast raised
Published on 07/14/2026 at 10:34, 44 minutes ago Original-Research: Vossloh AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 07/13/2026 at 18:00, 17 hours 18 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 17 hours 18 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 17 hours 18 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
